1 - 2 / 2 ![]() ![]() ![]() ![]() |
1. Glucagon-like peptide-1 receptor agonists in the management of type 2 diabetes mellitus and obesity Jasna Klen, Vita Dolžan, 2022, pregledni znanstveni članek Ključne besede: type 2 diabetes mellitus, obesity, GLP‐1 receptor agonists, incretins, cardiovascular safety, genetic polymorphisms |
2. Association of myocardial infarction with CDKN2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 polymorphism in Slovenian subjects with type 2 diabetes mellitus Miha Tibaut, Franjo Naji, Danijel Petrovič, 2022, izvirni znanstveni članek Ključne besede: type 2 diabetes mellitus, myocardial infarction, coronary artery disease, Cyclin Dependent Kinase Inhibitor 2B Antisense RNA 1, CDKN2B-AS1, rs1333049 |